The rise of copyright’s blockbuster initially sparked a period of growth for the drug industry, but recent shifts present a complicated picture for shareholders. Lower-cost competitors are eroding earnings, and https://cecilywqqc866787.ssnblog.com/39823470/sildenafil-and-pharma-a-volatile-bet